A. Nolly-Loyaga, Sandra Perez-Mantilla, Claudia Aguilar-Ydiáquez, L. Otiniano-Ramos, Antony Perez-Plasencia, Indira Poma-Reyes, R. Aguirre-Flores, María Reyes-Beltrán
{"title":"Intermittent fasting in non-communicable diseases: current evidence","authors":"A. Nolly-Loyaga, Sandra Perez-Mantilla, Claudia Aguilar-Ydiáquez, L. Otiniano-Ramos, Antony Perez-Plasencia, Indira Poma-Reyes, R. Aguirre-Flores, María Reyes-Beltrán","doi":"10.17268/RMT.2021.V16I02.10","DOIUrl":"https://doi.org/10.17268/RMT.2021.V16I02.10","url":null,"abstract":"","PeriodicalId":150228,"journal":{"name":"Revista Médica de Trujillo","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116861973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
F. Arméstar, B. Quirant, M. Quesada, José María Manciño, E. Martínez
{"title":"Monitoring by coronavirus antibodies of a family nucleus","authors":"F. Arméstar, B. Quirant, M. Quesada, José María Manciño, E. Martínez","doi":"10.17268/rmt.2020.v15i04.10","DOIUrl":"https://doi.org/10.17268/rmt.2020.v15i04.10","url":null,"abstract":"","PeriodicalId":150228,"journal":{"name":"Revista Médica de Trujillo","volume":"76 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124981798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Education Perspective in Times of COVID-19 Pandemic","authors":"G. F. Flores, Marlen A. Floriano","doi":"10.17268/rmt.2020.v15i04.02","DOIUrl":"https://doi.org/10.17268/rmt.2020.v15i04.02","url":null,"abstract":"","PeriodicalId":150228,"journal":{"name":"Revista Médica de Trujillo","volume":"64 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126289130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Phenylketonuria and the neonatal screnning importance","authors":"V. Sánchez-Reyna, Claudia Quispe-Castañeda","doi":"10.17268/rmt.2020.v15i04.09","DOIUrl":"https://doi.org/10.17268/rmt.2020.v15i04.09","url":null,"abstract":"Objetivo: Señalar la importancia de realizar tamiz neonatal de forma universal de Fenilcetonuria. Material y Método: Revisión de Historia Clínica y literatura. Resultado: (Caso Clínico) Recién nacido de sexo femenino, dado de alta como recién nacido sana, con resultado de tamiz neonatal para Fenilcetonuria de 7,789 mg/dl de Fenilalanina en sangre (Valor Normal < 3 mg/dl), valor de segunda muestra: 27,210 mg/dl, paciente es transferida al Hospital Edgardo Rebagliati MartinsLima-Perú. Se trató con formula libre de Fenilalanina y rica en tirosina. Conclusión. La FCU puede ser diagnosticada tempranamente por tamiz neonatal, realizado de rutina en ESSALUD; sin embargo, existen niños a los que no se les práctica, por lo que es muy importante reconocer la enfermedad para diagnosticarla previo al daño neurológico, así como incorporar el programa de tamizaje neonatal en toda entidad de salud. Palabras clave. Fenilcetonuria, tamizaje neonatal, tirosina (DeCS).","PeriodicalId":150228,"journal":{"name":"Revista Médica de Trujillo","volume":"625 ","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133522924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Factors associated with chronic kidney disease in type 2 diabetics treated regularly in Hospital I.","authors":"C. A. Arana-Calderón, Sandra Paola Chávez-Guevara","doi":"10.17268/rmt.2020.v15i04.05","DOIUrl":"https://doi.org/10.17268/rmt.2020.v15i04.05","url":null,"abstract":"RESUMEN Introducción: El 50 % de diabéticos padece de enfermedad renal crónica (ERC), siendo la ECV la principal causa de morbimortalidad en ellos, sin embargo, esto se da porque los pacientes con ERC mueren por eventos cardiovasculares antes de llegar a enfermedad renal terminal debido a que el daño cardiovascular inicia en una etapa temprana de la enfermedad renal, siendo necesario conocer los factores asociados al desarrollo de ERC en estadios iniciales de dicha enfermedad. Objetivo general: Determinar los factores asociados al desarrollo de ERC en pacientes diabéticos tipo 2 que se atienden de forma regular en un Hospital I. Materiales y métodos:Se realizo un estudio descriptivo de corte trasversal. Resultados: Se incluyeron 218 pacientes, encontrándose diferencia estadística significativa en la edad, HbA1c, nefroprotección y LDL-colesterol (p<0,05). Siendo la edad > a 60 años y la HbA1c ≥ 7%, factores de riesgo con un OR de 2,01 y 1,87 respectivamente, mientras que, el tener nefroprotección y cifras menores de 100mg/dl de LDL-colesterol fueron factores protectores contra el riesgo de desarrollar ERC al tener un OR de 0,52 y 0,53 respectivamente. Conclusión:Los factores asociados con el desarrollo de ERC en pacientes diabéticos son la edad, HbA1c, nefroprotección y LDL-colesterol. Palabras clave Enfermedad renal crónica, diabetes mellitus tipo 2, factor de riesgo y factor protector. SUMMARY Introduction: 50% of diabetics suffer from chronic kidney disease (CKD), with cardiovascular disease being the main cause of morbidity and mortality in them, however, this occurs because patients with CKD die from cardiovascular events before reaching end-stage renal disease due to that cardiovascular damage begins at an early stage of kidney disease, being necessary to know the factors associated with the development of CKD in the early stages of said disease.Overall objective: To determine the factors associated with the development of CKD in type 2 diabetic patients who are treated regularly in a Hospital I. Materials and methods: A descriptive cross-sectional study was carried out. Results: 218 patients were included, finding a statistically significant difference in age, HbA1c, nephroprotection and LDL-cholesterol (p <0.05). Being age> 60 years old and HbA1c ≥ 7%, risk factors with an OR of 2.01 and 1.87, respectively, while having nephroprotection and less than 100mg / dl of LDL-cholesterol were protective factors against the risk of develop ERC by having an OR of 0.52 and 0.53 respectively. Conclusion: The factors associated with the development of CKD in diabetic patients are age, HbA1c, nephroprotection and LDL-cholesterol.","PeriodicalId":150228,"journal":{"name":"Revista Médica de Trujillo","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131538500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Vaccines against COVID-19","authors":"J. Huamán-Saavedra","doi":"10.17268/rmt.2020.v15i04.01","DOIUrl":"https://doi.org/10.17268/rmt.2020.v15i04.01","url":null,"abstract":"","PeriodicalId":150228,"journal":{"name":"Revista Médica de Trujillo","volume":"55 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114767043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
L. Camacho-Saavedra, J. Huamán-Saavedra, Jorge Plasencia-Álvarez
{"title":"Efficiency of three-option multiple choice question","authors":"L. Camacho-Saavedra, J. Huamán-Saavedra, Jorge Plasencia-Álvarez","doi":"10.17268/rmt.2020.v15i04.06","DOIUrl":"https://doi.org/10.17268/rmt.2020.v15i04.06","url":null,"abstract":"1 Profesor Asociado Sección Farmacología. Departamento de Ciencias Básicas Médicas. Facultad de Medicina. Universidad Nacional de Trujillo. 2 Médico especialista en Medicina Interna. Hospital II Florencia de Mora – Essalud 3 Profesor Principal Sección Bioquímica. Departamento de Ciencia Básicas Médicas. 4 Profesor Auxiliar Sección Bioquímica. Departamento de Ciencia Básicas Médicas. Facultad de Medicina. Universidad Nacional de Trujillo. a Magister b Orcid: https://orcid.org/0000-0002-9680-2010 c Doctor. d Orcid: https://orcid.org/0000-0003-3842-555X e Orcid: https://orcid.org/00000003-3979-8382]","PeriodicalId":150228,"journal":{"name":"Revista Médica de Trujillo","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124800414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Risk factors associated with necrotizing enterocolitis in very premature newborns, Victor Lazarte Echegaray Hospital, 2013-2018","authors":"V. Sánchez-Reyna, L. Cisneros-Infantas","doi":"10.17268/rmt.2020.v15i04.07","DOIUrl":"https://doi.org/10.17268/rmt.2020.v15i04.07","url":null,"abstract":"Introduction: Necrotizing enterocolitis is the most frequent surgical emergency with a high mortality rate. There are factors associated with this, for example the use of Pulmonary Surfactant, age, birth weight, type of delivery, the administration of coffee citrate and continuous positive presion. Objectives: To determine the factors associated with necrotizing enterocolitis in moderate preterm neonates of the Lazarte Hospital 2013-2018. Materials and methods: Observational, analytical study of cases and controls. We reviewed 225 clinical histories of neonates under selection criteria. In the analysis, logistic regression was used. Results: Those who had necrotizing enterocolitis (ENC) had 29 weeks of age with RI: 28-32 and birth weight of 1524 with RI: 1205-1996. The 21.14% (n=26) of those who used the Pulmonary Surfactant had ENC, and in the same way 32.95% (n = 57) and 33.51% (n = 64) of those who had use of Caffeine Citrate and CPAP. For the type of delivery, from cesarean and vaginal way, 32.97% (n=61) and 37.5% (n=15) had ENC. In the bivariate analysis, the use of pulmonary surfactant was significant (ORc: 0.43, CI: 0.29-0.64, p=0.0001). Conclusions: Independently, only the use of surfactant was associated with ENC, being the use of surfactant a protective factor.","PeriodicalId":150228,"journal":{"name":"Revista Médica de Trujillo","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132608940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
